New Guidance on COVID-19 Vaccine “Booster” Doses
The U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) for both the Pfizer-BioNTech COVID-19 Vaccine and the Moderna COVID-19 Vaccine to allow for the use of an additional dose (third shot) in certain immunocompromised individuals. You may qualify for a booster of Moderna or Pfizer if you meet the following criteria:
- You have already completed the two-dose vaccine series of Pfizer or Moderna
- Your vaccine series was completed over 28 days ago
- You meet any of the following criteria for having a weakened immune system:
- Currently receiving active cancer treatment for tumors or cancers of the blood.
- Received an organ transplant and are taking medicine to suppress the immune system.
- Received a stem cell transplant within the last two years
- Taking medicine to suppress the immune system.
- Moderate or severe primary immunodeficiency (such as DiGeorge syndrome or Wiskott-Aldrich syndrome).
- Advanced or untreated HIV infection.
- Active treatment with high-dose corticosteroids or other drugs that may suppress your immune response.
If you meet the criteria above, you are qualified to click the button below and schedule a booster dose of the Pfizer or Moderna COVID-19 vaccines. It is recommended to get a booster of the same vaccine brand you originally received.
Continue to watch our COVID-19 Vaccines page, as well as our social media, for updates about appointment scheduling and availability.